Nomura Holdings’s GeneDx Holdings WGS Stock Holding History

Nomura Holdings’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-70,000	Closed	-$6.2M	–	1992
2025 Q1	$6.2M	Buy	+70,000	New	+$6.07M	0.01%	630

Other funds holding WGS

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Nomura Holdings's WGS Position: Q1 2022 in Review

Nomura Holdings sold out of GeneDx Holdings (WGS) in Q1 2022, closing a stake of 9,586 shares — an estimated $1.41M sold.

Nomura Holdings first reported a position in WGS in Q3 2021 and held it in 2 quarters. The position peaked at $2.41M in Q3 2021. 108 funds tracked by Wall St. Rank hold WGS as of Q1 2022.

Nomura Holdings reported no remaining GeneDx Holdings position as of Q1 2022 after selling out during the quarter.
Nomura Holdings sold 9,586 GeneDx Holdings shares in Q1 2022, an estimated $1.41M.
Nomura Holdings first reported a position in GeneDx Holdings in Q3 2021 and held it in 2 quarters.
Nomura Holdings's GeneDx Holdings position peaked at $2.41M in Q3 2021.
108 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2022.

Based on Nomura Holdings's 13F filing for Q1 2022, filed 18 May 2022.